Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas ; volume:14 ; number:1 ; day:22 ; month:9 ; year:2023 ; pages:1-15 ; date:12.2023
Nature Communications ; 14, Heft 1 (22.9.2023), 1-15, 12.2023
- Urheber
-
Yin, Jianxing
Wang, Xiefeng
Ge, Xin
Ding, Fangshu
Shi, Zhumei
Ge, Zehe
Huang, Guang
Zhao, Ningwei
Chen, Dongyin
Zhang, Junxia
Agnihotri, Sameer
Cao, Yuandong
Ji, Jing
Lin, Fan
Wang, Qianghu
Zhou, Qigang
Wang, Xiuxing
You, Yongping
Lu, Zhimin
Qian, Xu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-41663-2
- URN
-
urn:nbn:de:101:1-2024020210240221148615
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 02:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yin, Jianxing
- Wang, Xiefeng
- Ge, Xin
- Ding, Fangshu
- Shi, Zhumei
- Ge, Zehe
- Huang, Guang
- Zhao, Ningwei
- Chen, Dongyin
- Zhang, Junxia
- Agnihotri, Sameer
- Cao, Yuandong
- Ji, Jing
- Lin, Fan
- Wang, Qianghu
- Zhou, Qigang
- Wang, Xiuxing
- You, Yongping
- Lu, Zhimin
- Qian, Xu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma
Drug metabolism-related gene ABCA1 augments temozolomide chemoresistance and immune infiltration abundance of M2 macrophages in glioma
STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B
IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
Somatic retrotransposition is infrequent in glioblastomas
Bevacizumab for patients with recurrent multifocal glioblastomas
GATA4 and DcR1 methylation in glioblastomas
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells
A mathematical approach to virus therapy of glioblastomas
Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma
Drug metabolism-related gene ABCA1 augments temozolomide chemoresistance and immune infiltration abundance of M2 macrophages in glioma
STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B
IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
Somatic retrotransposition is infrequent in glioblastomas
Bevacizumab for patients with recurrent multifocal glioblastomas
GATA4 and DcR1 methylation in glioblastomas
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells
A mathematical approach to virus therapy of glioblastomas
Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma
Drug metabolism-related gene ABCA1 augments temozolomide chemoresistance and immune infiltration abundance of M2 macrophages in glioma
STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B
IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
Somatic retrotransposition is infrequent in glioblastomas
Bevacizumab for patients with recurrent multifocal glioblastomas
GATA4 and DcR1 methylation in glioblastomas
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells